Regeneron Pharma (REGN) PT Lowered to $730 at Morgan Stanley
Morgan Stanley analyst Matthew Harrison ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)